Humaliv PC 150mg/100mg Tablet is a combination pharmaceutical formulation containing L-Ornithine L-Aspartate (150mg) and Pancreatin (100mg), designed to support hepatic function and improve digestive enzyme activity. L-Ornithine L-Aspartate is an amino acid compound that plays a critical role in the detoxification of ammonia in the liver, thereby aiding in the management of hepatic encephalopathy and other liver-related metabolic disturbances. Pancreatin, a mixture of digestive enzymes including amylase, lipase, and protease, facilitates the breakdown of carbohydrates, fats, and proteins, enhancing nutrient absorption in patients with pancreatic insufficiency or digestive disorders. Humaliv PC is indicated for use in conditions such as chronic liver diseases, hepatic encephalopathy, and exocrine pancreatic insufficiency, where both liver detoxification and digestive enzyme supplementation are required. The tablet formulation ensures convenient oral administration and optimal bioavailability. It is recommended to be used under medical supervision, with dosage adjusted according to the severity of the condition and patient response. Common precautions include monitoring for allergic reactions and gastrointestinal disturbances. Humaliv PC serves as an adjunct therapy aimed at improving metabolic function and nutritional status in affected patients.